Back to Search
MICHAEL CHAMBERLAIN, MD
MD
Neurology Physician
NPI: 1649859257IndividualAccepts Medicare
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 2021
Research & Publications (20)
Salvage therapy with single agent bevacizumab for recurrent glioblastoma.
PMID 19593660·J Neurooncol·2010
3-trial
Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology.
PMID 19235827·Cancer·2009
4-observational
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.
PMID 18820836·J Neurooncol·2009
3-trial
Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma.
PMID 18953491·J Neurooncol·2009
8-other
Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
PMID 19139302·Arch Neurol·2009
8-other
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
PMID 19569246·Cancer·2009
8-other
Neurolymphomatosis: a rare metastatic complication of diffuse large B-Cell lymphoma.
PMID 19448975·J Neurooncol·2009
5-case
Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma.
PMID 19197992·Cancer·2009
8-other
Risk of neoplastic meningitis following surgical resection of cerebellar metastases.
PMID 18438610·J Neurooncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4403 HARRISON BLVD STE 2815
OGDEN, UT 84403 - Phone
- (801) 387-7880
Quick Facts
- NPI
- 1649859257
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile